article thumbnail

7 ‘Hidden Gem’ Hospice News Stories in 2024

Hospice News

Meanwhile, Addus HomeCare Corporation (Nasdaq: ADUS) and Gentiva also completed one of the largest deals of the year. About 6% of hospice providers indicated plans to diversify their services to include end-of-life doulas in the Hospice News 2024 Outlook Survey. This year, it made moves to acquire Amedisys for an estimated $3.3

2024 264
article thumbnail

Clinical Capacity Propelling Enhabit’s Hospice Growth

Hospice News

Hospice currently represents about 20% of Enhabits patient volume, CEO Barbara Jacobsmeyer said at the HomeCare 100 conference in Florida. The companys average daily hospice census in Q3 2024 rose 6.9% Improved staffing conditions have turned hospice into a growth engine for Enhabit Inc. NYSE: EHAB).

Hospice 264
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Addus HomeCare Expects 2024 Acquisitions

Hospice News

Addus HomeCare Corp. The post Addus HomeCare Expects 2024 Acquisitions appeared first on Hospice News. NASDAQ: ADUS) is poised for further acquisitions, potentially including some hospice deals. The company is seeking to pair its clinical services with its personal business in its existing markets.

Homecare 203
article thumbnail

Organic Growth Top of Mind for Hospice Providers in 2025

Hospice News

Among 112 hospice professionals who responded to the 2024 Outlook Survey by Hospice News and Homecare Homebase, 60% said that expanding current locations would be the growth tactic they plan to use the most during 2025. Hospices in 2025 are laser-focused on organic growth rather than other tactics like acquisitions.

2025 225
article thumbnail

Addus HomeCare to Accelerate Acquisition Activity

Hospice News

Though the acquisition market has slowed down this year for home-based care companies, Addus HomeCare Corp. Addus has been among the few publicly traded companies that have remained active acquirers, and more deals are likely on the way during the fourth quarter and into 2024. NASDAQ: ADUS) remains on the hunt.

Homecare 263
article thumbnail

Addus Taking ‘Conservative’ Approach to Hospice, Home Health M&A

Hospice News

Addus HomeCare Corporation (Nasdaq: ADUS) may slow down on mergers and acquisitions in the near term as it absorbs Gentiva’s personal care business. million in the Q3 of 2024, a 7% year-over-year increase. The company’s third quarter adjusted EBITDA margin reached 11.1%, which was +2.1% Addus’ total revenue reached $289.8

Hospice 276
article thumbnail

Hospice Investors to Watch in 2024

Hospice News

Though the number of hospice M&A deals plummeted in 2023 compared to prior years, deals are still being made, and the industry may see a rebound in 2024. The following are some potential buyers to watch in 2024. But the company is almost certainly not done in the acquisition game, and further activity is likely in 2024.

2024 278